Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99.6M
-
Number of holders
-
269
-
Total 13F shares, excl. options
-
91.1M
-
Shares change
-
+945K
-
Total reported value, excl. options
-
$8.95B
-
Value change
-
+$109M
-
Put/Call ratio
-
1
-
Number of buys
-
135
-
Number of sells
-
-119
-
Price
-
$98.24
Significant Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q2 2018
327 filings reported holding NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock as of Q2 2018.
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) has 269 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91.1M shares
of 99.6M outstanding shares and own 91.46% of the company stock.
Largest 10 shareholders include FMR LLC (13.5M shares), VANGUARD GROUP INC (7.57M shares), JANUS HENDERSON GROUP PLC (7.41M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.93M shares), BlackRock Inc. (5.08M shares), PERCEPTIVE ADVISORS LLC (4.72M shares), BB BIOTECH AG (3.32M shares), WELLINGTON MANAGEMENT GROUP LLP (2.41M shares), Invesco Ltd. (2.07M shares), and Artisan Partners Limited Partnership (1.88M shares).
This table shows the top 269 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.